Efficacy and Safety of Once‐Daily Prolonged‐Release Pregabalin for the Treatment of Patients With Diabetic Peripheral Neuropathy: A Randomized, Double‐Blind, Active, and Placebo‐Controlled Trial

20251 citationsJournal Article

Authors

The efficacy and safety of pregabalin PR was comparable to pregabalin IR for the treatment of pain in patients with DPN.

Good health and well-being

Published in: Pain Practice

Volume 25, Issue 7, pp. e70061-e70061

Field-Weighted Citation Impact: 1.22